IRONWOOD PHARMACEUTICALS, INC. (IRWD) Free cash flow 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$127.0MFY2025 · since FY2016: -$30.1M → $127.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $127.0M | +22.8% |
| FY2024 | $103.4M | -43.5% |
| FY2023 | $183.2M | -33.1% |
| FY2022 | $273.6M | +4.6% |
| FY2021 | $261.6M | +56.7% |
| FY2020 | $167.0M | +4622.7% |
| FY2019 | $3.5M | +105.0% |
| FY2018 | -$71.2M | +31.2% |
| FY2017 | -$103.6M | -243.6% |
| FY2016 | -$30.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Operating cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →